Los Angeles, CA.  October 25, 2021 – US Nuclear’s (OTCQB: UCLE) partner Grapheton recently hired a new CEO, Terry Lingren, to accelerate product development by raising funds and allowing founder and CTO Sam Kassegne to focus on research and development.

Sam is the creative genius behind Grapheton’s glassy carbon supercapacitor technology that can benefit us all by speeding up EV chargers, augmenting or replacing EV onboard batteries, developing a new generation of computer chips with tiny supercapacitors, and advancing the treatment of neurological diseases and brain, spinal, and prosthetic cases. Mr. Lingren has significant experience raising capital, growing profitable businesses, and bringing high-tech products to market-clearing the way for rapid product development at Grapheton. Sam and Grapheton are also assisted by a scientific advisory board of 5 prestigious members specializing in fields such as bioengineering, neural technology, rehabilitative technology and medicine, microfabrication, and commercializing cutting-edge technology.

Grapheton is in several emerging industries (brain-computer interface, neural probes, and devices, supercapacitors for EV charging, and computer chip applications) which are clear opportunities for investors. Looking forward, Grapheton expects to have a number of income streams from these emerging industries where its patents and disruptive high-tech products and services are highly needed.

Team

About Grapheton, Inc.

Founded in 2019, Grapheton is an early-stage company commercializing brain probes and power sources made from glassy carbon and graphene. These probes are completely biocompatible, corrosion-resistant, and non-toxic and can remain in the body for over ten years, unlike other probes which must be replaced every two years or less. Dr. Kassegne, a professor at San Diego State University who had served as Deputy Director of the National Science Foundation’s Center for Neurotechnology, has worked for over ten years with collaborators at the University of Washington and Massachusetts Institute of Technology (MIT). He and his team have three patents around the use of glassy carbon for brain probes and supercapacitors, as well as interconnecting glassy carbon with graphene.

Contact Grapheton:
Terry Lingren
(619) 990-5728
contact@grapheton.com
http://www.grapheton.com

 

Safe Harbor Act

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at https://www.usnuclearcorp.com

CONTACT:

US Nuclear Corp. (UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email: info@usnuclearcorp.com